Alkermes (ALKS) EV to CFO (2010 - 2026)
Alkermes' (ALKS) quarterly EV to CFO came in at 55.95 in Q2 2026, up 126.72% year-over-year from 24.68 in Q2 2025, and up 272.54% quarter-over-quarter from 32.43 in Q1 2026.
Analysis
Alkermes (ALKS) EV to CFO (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported EV to CFO for 17 consecutive years, with 55.95 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to CFO rose 126.72% year-over-year to 55.95 in Q2 2026; TTM through Jun 2026 was 32.34, a 354.55% increase from a year earlier, with the FY2025 full-year figure at 6.75, down 24.27% from the prior year.
- EV to CFO was 55.95 for Q2 2026 at Alkermes, up from 32.43 in the prior quarter.
- Over five years, EV to CFO peaked at 4941.93 in Q3 2022 and troughed at 1869.7 in Q2 2022.
- A 5-year average of 393.92 and a median of 36.88 in 2023 frame the typical range for EV to CFO.
- The widest YoY moves for EV to CFO: up 9142.41% in 2022, down 1909.32% in 2022.
- Over 5 years, EV to CFO stood at 3521.21 in 2022, then sank by 98.98% to 35.98 in 2023, then plunged by 42.89% to 20.55 in 2024, then gained by 0.55% to 20.66 in 2025, then jumped by 170.78% to 55.95 in 2026.
- The last three EV to CFO figures came in at 55.95 (Q2 2026), 32.43 (Q1 2026), and 20.66 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.03 Bn | 625.27 Bn | 17.26 Bn |
| 2 | AbbVie | 441.99 Bn | 435.42 Bn | 12.70 Bn |
| 3 | Merck | 366.30 Bn | 359.16 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - |
| 8 | Incyte | 25.53 Bn | 20.99 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.51 Bn | 18.85 Bn | 683.80 Mn |
| 10 | Alkermes | 7.56 Bn | 6.91 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.95 |
| Mar 31, 2026 | -32.43 |
| Dec 31, 2025 | 20.66 |
| Sep 30, 2025 | 37.79 |
| Jun 30, 2025 | 24.68 |
| Mar 31, 2025 | 46.14 |
| Dec 31, 2024 | 20.55 |
| Sep 30, 2024 | 44.36 |
| Jun 30, 2024 | 21.38 |
| Mar 31, 2024 | 181.67 |
| Dec 31, 2023 | 35.98 |
| Sep 30, 2023 | 37.92 |
| Jun 30, 2023 | 20.32 |
| Mar 31, 2023 | -191.57 |
| Dec 31, 2022 | 3,521.21 |
| Sep 30, 2022 | 4,941.93 |
| Jun 30, 2022 | -1,869.70 |
| Mar 31, 2022 | 173.69 |
| Dec 31, 2021 | 104.13 |
| Sep 30, 2021 | 53.47 |